Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Combination immunotherapy for tumors via sequential intratumoral injection of oncolytic herpes simplex virus - type 1 and immature dendritic cells

Combination immunotherapy for tumors via sequential intratumoral injection of oncolytic herpes simplex virus - type 1 and immature dendritic cells. Clinical Cancer Research. 2008; 14(23):7711-6.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.